Fortis Hospital Launches Institute for Gene-Targeted Healthcare in Delhi
New facility aims to revolutionize treatment for cancer, heart, and neurological diseases
Fortis Healthcare has unveiled the Fortis Institute of Genomic Medicine in Delhi, a groundbreaking initiative aimed at advancing personalized and gene-targeted healthcare for critical diseases such as cancer, heart conditions, and neurological disorders.

The institute, which officially launched on Tuesday, will focus on integrating genomic medicine into routine healthcare practices, leveraging genetic testing to offer more precise diagnoses, treatments, and early disease detection. This approach is expected to significantly improve outcomes for patients, particularly those with complex or hereditary conditions.

A key feature of the institute is its collaborative approach, bringing together a diverse range of medical experts from fields including oncology, cardiology, neurology, pathology, and genomics. The multidisciplinary team will work closely to utilize cutting-edge genomic technologies to develop tailored treatment plans for patients.

“This institute represents a significant step forward in our commitment to advancing medical research and delivering highly effective, patient-centric care,” said a statement from Fortis Healthcare. The use of genomic data in healthcare allows for the identification of genetic predispositions to diseases, enabling earlier interventions and personalized care strategies.

With this new facility, Fortis aims to not only improve the diagnosis and treatment of existing diseases but also drive innovations in genomic research that could pave the way for future breakthroughs in healthcare. The institute is expected to be a hub for research, education, and development in the rapidly evolving field of genomic medicine.

This move aligns with a global shift towards precision medicine, where genetic insights play a pivotal role in shaping health interventions and outcomes.